High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer
- PMID: 35326703
- PMCID: PMC8945895
- DOI: 10.3390/cancers14061552
High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer
Abstract
The increase incidence of early colorectal cancer (T1 CRC) last years is mainly due to the introduction of population-based screening for CRC. T1 CRC staging based on histological criteria remains challenging and there is high variability among pathologists in the scoring of these criteria. It is crucial to unravel the biology behind the progression of adenoma into T1 CRC. Glycomic studies have reported extensively on alterations of the N-glycomic pattern in CRC; therefore, investigating these alterations may reveal new insights into the development of T1 CRC. We used matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging (MSI) to spatially profile the N-glycan species in a cohort of pT1 CRC using archival formalin-fixed and paraffin-embedded (FFPE) material. To generate structural information on the observed N-glycans, CE-ESI-MS/MS was used in conjunction with MALDI-MSI. Relative intensities and glycosylation traits were calculated based on a panel of 58 N-glycans. Our analysis showed pronounced differences between normal epithelium, dysplastic, and carcinoma regions. High-mannose-type N-glycans were higher in the dysplastic region than in carcinoma, which correlates to increased proliferation of the cells. We observed changes in the cancer invasive front, including higher expression of α2,3-linked sialic acids which followed the glycosylation pattern of the carcinoma region.
Keywords: MALDI-MSI; N-glycosylation; colorectal cancer; early cancer progression; mass spectrometry imaging; molecular histology.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.Mol Cell Proteomics. 2016 Sep;15(9):3003-16. doi: 10.1074/mcp.M116.059816. Epub 2016 Jul 13. Mol Cell Proteomics. 2016. PMID: 27412689 Free PMC article.
-
Differential N-glycosylation profiling of formalin-fixed paraffin-embedded (FFPE) invasive ductal carcinoma tissues using MALDI-TOF-MS.Mol Omics. 2021 Jun 14;17(3):394-404. doi: 10.1039/d0mo00150c. Mol Omics. 2021. PMID: 33735360
-
MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.Proteomics. 2019 Nov;19(21-22):e1800482. doi: 10.1002/pmic.201800482. Epub 2019 Aug 16. Proteomics. 2019. PMID: 31364262
-
MALDI Mass Spectrometry Imaging of N-Linked Glycans in Tissues.Adv Exp Med Biol. 2018;1104:59-76. doi: 10.1007/978-981-13-2158-0_4. Adv Exp Med Biol. 2018. PMID: 30484244 Review.
-
Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.Acc Chem Res. 2016 Oct 18;49(10):2099-2106. doi: 10.1021/acs.accounts.6b00193. Epub 2016 Sep 21. Acc Chem Res. 2016. PMID: 27653471 Review.
Cited by
-
Optimized protocol for MALDI MSI of N-glycans using an on-tissue digestion in fresh frozen tissue sections.Sci Rep. 2023 Feb 16;13(1):2776. doi: 10.1038/s41598-023-29560-6. Sci Rep. 2023. PMID: 36797298 Free PMC article.
-
Invertebrate C1q Domain-Containing Proteins: Molecular Structure, Functional Properties and Biomedical Potential.Mar Drugs. 2023 Oct 30;21(11):570. doi: 10.3390/md21110570. Mar Drugs. 2023. PMID: 37999394 Free PMC article. Review.
-
Mass spectrometry imaging of N-linked glycans: Fundamentals and recent advances.Mass Spectrom Rev. 2024 Jun 27:10.1002/mas.21895. doi: 10.1002/mas.21895. Online ahead of print. Mass Spectrom Rev. 2024. PMID: 38934211 Review.
-
Integrated glycoproteomic characterization of clear cell renal cell carcinoma.Cell Rep. 2023 May 30;42(5):112409. doi: 10.1016/j.celrep.2023.112409. Epub 2023 Apr 18. Cell Rep. 2023. PMID: 37074911 Free PMC article.
-
Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2021-2022.Mass Spectrom Rev. 2025 May-Jun;44(3):213-453. doi: 10.1002/mas.21873. Epub 2024 Jun 24. Mass Spectrom Rev. 2025. PMID: 38925550 Free PMC article. Review.
References
-
- Hari D.M., Leung A.M., Lee J.-H., Sim M.-S., Vuong B., Chiu C.G., Bilchik A.J. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: Do the complex modifications improve prognostic assessment? J. Am. Coll. Surg. 2013;217:181–190. doi: 10.1016/j.jamcollsurg.2013.04.018. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources